XML 52 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
INTANGIBLE ASSETS (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Finite-Lived Intangible Assets    
Accumulated Amortization $ (349,264) $ (272,141)
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 4,120,794 3,371,888
Net Amount 3,771,530 3,099,747
Hormone Therapy Drug Candidate Patents - (Pending) [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 1,749,561 1,721,305
Net Amount 1,749,561 1,721,305
Multiple Trademarks [Member]    
Indefinite-Lived Intangible Assets    
Gross Carrying Amount 255,749 233,275
Net Amount 255,749 233,275
Domestic Utilty Patent - Opera Software [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount 31,951 31,951
Accumulated Amortization (9,985) (8,487)
Net Amount $ 21,966 $ 23,464
Weighted average remaining amortization period 11 years 11 years 9 months
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 1,991,790 $ 1,293,614
Accumulated Amortization (247,536) (171,911)
Net Amount $ 1,744,254 $ 1,121,703
Weighted average remaining amortization period 14 years 3 months 15 years
Development Costs Of Corporate Website [Member]    
Finite-Lived Intangible Assets    
Gross Carrying Amount $ 91,743 $ 91,743
Accumulated Amortization $ (91,743) $ (91,743)